Skip to main content
Top

Familial Cancer

Issue 3-4/2004

Content (16 Articles)

Foreword

Steven M. Lipkin

Cancer in Jews: introduction and overview

Henry T. Lynch, Wendy S. Rubinstein, Gershon Y. Locker

A636P testing in Ashkenazi Jews

G. guillem Jose, G. moore Harvey, Palmer Crystal, Glogowski Emily, Rob Finch, Nafa Khedoudja, J. Markowitz Arnold, Offit Kenneth, A. Ellis Nathan

Familial pancreatic carcinoma in Jews

Henry T Lynch, Carolyn A Deters, Jane F Lynch, Randall E Brand

Fanconi anemia in Ashkenazi Jews

David I. Kutler, Arleen D. Auerbach

Hereditary breast cancer in Jews

Wendy S. Rubinstein

Hereditary ovarian cancer in Ashkenazi Jews

Luis Robles-díaz, Deborah J Goldfrank, Noah D Kauff, Mark Robson, Kenneth Offit

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine